An overview of influenza viruses and vaccines

RF Nuwarda, AA Alharbi, V Kayser - Vaccines, 2021 - mdpi.com
Influenza remains one of the major public health concerns because it causes annual
epidemics and can potentially instigate a global pandemic. Numerous countermeasures …

Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection

S Bournazos, D Corti, HW Virgin, JV Ravetch - Nature, 2020 - nature.com
Antibodies against viral pathogens represent promising therapeutic agents for the control of
infection, and their antiviral efficacy has been shown to require the coordinated function of …

A guide to the use of bioassays in exploration of natural resources

J Sabotič, E Bayram, D Ezra, SP Gaudêncio… - Biotechnology …, 2024 - Elsevier
Bioassays are the main tool to decipher bioactivities from natural resources thus their
selection and quality are critical for optimal bioprospecting. They are used both in the early …

Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo

JE Edgar, S Trezise, RM Anthony… - Proceedings of the …, 2023 - National Acad Sciences
Antibody responses against highly conserved epitopes on the stalk domain of influenza
virus hemagglutinin (HA) confer broad protection; however, such responses are limited. To …

Temporal links between self-reported sleep and antibody responses to the influenza vaccine

AA Prather, SD Pressman, GE Miller… - International journal of …, 2021 - Springer
Background Growing evidence suggests that sleep plays an important role in immunological
memory, including antibody responses to vaccination. However, much of the prior research …

Immunogenicity of high-dose versus MF59-adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the swiss/spanish trial in solid organ …

M Mombelli, D Neofytos, U Huynh-Do… - Clinical infectious …, 2024 - academic.oup.com
Background The immunogenicity of the standard influenza vaccine is reduced in solid-organ
transplant (SOT) recipients, so new vaccination strategies are needed in this population …

Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV …

J Beicht, M Kubinski, I Zdora, C Puff… - Frontiers in …, 2023 - frontiersin.org
Introduction Tick-borne encephalitis virus (TBEV) is one of the most relevant tick-transmitted
neurotropic arboviruses in Europe and Asia and the causative agent of tick-borne …

A self-adjuvanted, modular, antigenic VLP for rapid response to influenza virus variability

J Sharma, K Shepardson, LL Johns… - … applied materials & …, 2020 - ACS Publications
The continuous evolution of influenza A virus (IAV) requires the influenza vaccine
formulations to be updated annually to provide adequate protection. Recombinant protein …

Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza

X Cui, P Vervaeke, Y Gao, L Opsomer, Q Sun… - npj Vaccines, 2024 - nature.com
This study reports on the immunogenicity and biodistribution of H5 hemagglutinin (HA)-
based self-amplifying (sa) mRNA vaccines in mice. Four sa-mRNA vaccines encoding either …

A small molecule RIG-I agonist serves as an adjuvant to induce broad multifaceted influenza virus vaccine immunity

EA Hemann, ML Knoll, CR Wilkins, C Subra… - The Journal of …, 2023 - journals.aai.org
This project was initially conceived and directed by Y.-ML and MGRCI served as project
manager for all studies. EAH and Y.-ML designed experiments and analyzed data. CRW …